MT-CYB and Chagas disease: Moreover, this innate flexibility suggests that profiling of polar metabolites in T. cruzi to identify cytochrome b inhibitors is a strategy that will be successful in other laboratories without extensive method development, facilitating an effective counter-screen for use during Chagas’ disease drug discovery.